CBS4's Hank Tester reports on how Pfizer confirmed this week that an ongoing Phase 3 clinical trial of its coronavirus vaccine remains highly effective for at least six months after the second dose.
Daily Covid-19 Minute: Pfizer’s Six-Month Data
CBS 62 Detroit
Pfizer has revealed six-month follow-up data from their covid vaccine trial. They confirmed protection from their vaccine lasts for..
